{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:55:57Z","timestamp":1781650557959,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The watch &amp; wait concept in rectal cancer offers a promising non-operative strategy for patients who achieve a complete response following neoadjuvant radiochemotherapy (nRCT). However, accurately diagnosing clinical complete remission (cCR) based on clinical\u00a0examinations, endoscopy and imaging remains a major challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included patients with rectal cancer who received nRCT at the University Hospital Erlangen between May 2022 and July 2024 (radiation: 50.4\u201354 Gy or 5x5 Gy; chemotherapy: 5-FU and oxaliplatin, partially as part of a total neoadjuvant therapy (TNT) concept). Patients were analyzed based on their clinical, endoscopic, and radiological findings, and classified as having either consistent or discrepant diagnostic results. Particular attention was paid to patients with discrepancies between diagnostic modalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 78 patients underwent nRCT for rectal cancer during the study period. Six patients were excluded due to a second malignancy, tumor recurrence, or incomplete restaging. 72 patients were included in the final analysis. Of these, 46 patients showed consistent evidence of residual tumor during restaging, leading to surgical resection, with histopathological confirmation of residual tumor in 76% of cases. A clinical and radiological complete remission was observed in 12 of 72 patients (16.7%), four of whom experienced local regrowth.\u00a0Discrepancies were noted between clinical, endoscopic and radiological findings following nRCT in 14 patients (median age 68 years, range 40\u201373). Of these patients, 13 had a negative MRI and one had a negative endoscopy, despite differing findings on the other modalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Diagnosing complete remission after nRCT remains challenging within the context of a watch &amp; wait strategy. Our findings suggest that pelvic MRI may overestimate the response to treatment. This is consistent with published data. Discrepancies between clinical, endoscopic, and radiologic assessments should prompt caution and emphasize the need for individualized decision-making before surgery is omitted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00423-026-04047-w","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:36:29Z","timestamp":1776443789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discrepancies between clinical and radiological assessment of complete remission of rectal cancer after neoadjuvant radiochemotherapy"],"prefix":"10.1007","volume":"411","author":[{"given":"Katja","family":"Fechner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gr\u00fctzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Bittorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"4047_CR1","doi-asserted-by":"crossref","unstructured":"Habr-Gama A et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240(4): 711\u20137; discussion 717\u20138","DOI":"10.1097\/01.sla.0000141194.27992.32"},{"issue":"8","key":"4047_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","volume":"16","author":"AL Appelt","year":"2015","unstructured":"Appelt AL et al (2015) High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol 16(8):919\u201327","journal-title":"Lancet Oncol"},{"key":"4047_CR3","doi-asserted-by":"publisher","first-page":"114291","DOI":"10.1016\/j.ejca.2024.114291","volume":"210","author":"E Fokas","year":"2024","unstructured":"Fokas E et al (2024) Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO\/ARO\/AIO-12 and the OPRA randomized phase 2 trials. Eur J Cancer 210:114291","journal-title":"Eur J Cancer"},{"issue":"39","key":"4047_CR4","doi-asserted-by":"publisher","first-page":"42354","DOI":"10.18632\/oncotarget.6093","volume":"6","author":"J Li","year":"2015","unstructured":"Li J et al (2015) Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study. Oncotarget 6(39):42354\u201361","journal-title":"Oncotarget"},{"issue":"35","key":"4047_CR5","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","volume":"29","author":"M Maas","year":"2011","unstructured":"Maas M et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29(35):4633\u201340","journal-title":"J Clin Oncol"},{"key":"4047_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw291","author":"MH Martens","year":"2016","unstructured":"Martens MH, Maas M, Heijnen LA, Lambregts DM, Leijtens JW, Stassen LP, Breukink SO, Hoff C, Belgers EJ, Melenhorst J, Jansen R, Buijsen J, Hoofwijk TG, Beets-Tan RG, Beets GL (2016) Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer. J Natl Cancer Inst 108(12):djw171. https:\/\/doi.org\/10.1093\/jnci\/djw171","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4047_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","volume":"17","author":"AG Renehan","year":"2016","unstructured":"Renehan AG et al (2016) Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol 17(2):174\u2013183","journal-title":"Lancet Oncol"},{"issue":"6","key":"4047_CR8","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/SLA.0b013e3182759f1c","volume":"256","author":"JD Smith","year":"2012","unstructured":"Smith JD et al (2012) Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg 256(6):965\u201372","journal-title":"Ann Surg"},{"issue":"4","key":"4047_CR9","doi-asserted-by":"publisher","first-page":"e185896","DOI":"10.1001\/jamaoncol.2018.5896","volume":"5","author":"JJ Smith","year":"2019","unstructured":"Smith JJ et al (2019) Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy. JAMA Oncol 5(4):e185896","journal-title":"JAMA Oncol"},{"issue":"1","key":"4047_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.50903","volume":"7","author":"HM Thompson","year":"2024","unstructured":"Thompson HM et al (2024) Organ preservation and survival by clinical response grade in patients with rectal cancer treated with total neoadjuvant therapy: a secondary analysis of the OPRA randomized clinical trial. JAMA Netw Open 7(1):e2350903","journal-title":"JAMA Netw Open"},{"issue":"10139","key":"4047_CR11","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","volume":"391","author":"MJM van der Valk","year":"2018","unstructured":"van der Valk MJM et al (2018) Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 391(10139):2537\u20132545","journal-title":"Lancet"},{"issue":"5","key":"4047_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1200\/JCO.23.01208","volume":"42","author":"FS Verheij","year":"2024","unstructured":"Verheij FS et al (2024) Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial. J Clin Oncol 42(5):500\u2013506","journal-title":"J Clin Oncol"},{"issue":"1","key":"4047_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR et al (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22(1):29\u201342","journal-title":"Lancet Oncol"},{"key":"4047_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.radonc.2021.05.014","volume":"160","author":"M Jankowski","year":"2021","unstructured":"Jankowski M et al (2021) Watch-and-wait strategy in rectal cancer: is there a tumour size limit? Results from two pooled prospective studies. Radiother Oncol 160:229\u2013235","journal-title":"Radiother Oncol"},{"issue":"12","key":"4047_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41571-021-00538-5","volume":"18","author":"E Fokas","year":"2021","unstructured":"Fokas E et al (2021) International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nat Rev Clin Oncol 18(12):805\u2013816","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"4047_CR16","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1245\/s10434-015-4687-9","volume":"22","author":"M Maas","year":"2015","unstructured":"Maas M et al (2015) Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment. Ann Surg Oncol 22(12):3873\u201380","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"4047_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.annonc.2025.05.528","volume":"36","author":"RD Hofheinz","year":"2025","unstructured":"Hofheinz RD et al (2025) Localised rectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 36(9):1007\u20131024","journal-title":"Ann Oncol"},{"key":"4047_CR18","unstructured":"Leitlinienprogramm Onkologie (2019) S3-Leitlinie Kolorektales Karzinom, Langversion 2.1. http:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/kolorektales-karzinom\/ (AWMF Registernummer: 021\/007OL). Zugegriffen: 15.08.2025"},{"issue":"6","key":"4047_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S2468-1253(25)00049-4","volume":"10","author":"C Gani","year":"2025","unstructured":"Gani C et al (2025) Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO\/ARO\/AIO-16): an open-label, multicentre, single-arm, phase 2 trial. The Lancet Gastroenterology & Hepatology 10(6):562\u2013572","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"4047_CR20","doi-asserted-by":"publisher","first-page":"1477510","DOI":"10.3389\/fonc.2024.1477510","volume":"14","author":"H Williams","year":"2024","unstructured":"Williams H, Lee C, Garcia-Aguilar J (2024) Nonoperative management of rectal cancer. Front Oncol 14:1477510","journal-title":"Front Oncol"},{"issue":"5","key":"4047_CR21","doi-asserted-by":"publisher","first-page":"700","DOI":"10.4251\/wjgo.v15.i5.700","volume":"15","author":"D Cuicchi","year":"2023","unstructured":"Cuicchi D et al (2023) Restaging rectal cancer following neoadjuvant chemoradiotherapy. World J Gastrointest Oncol 15(5):700\u2013712","journal-title":"World J Gastrointest Oncol"},{"issue":"3","key":"4047_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000522006","volume":"103","author":"LC Conradi","year":"2022","unstructured":"Conradi LC, R\u00f6del C, Ghadimi M (2022) Rectal cancer: open questions in 2022 current standards of clinical practice and ongoing trials. Digestion 103(3):175\u2013182","journal-title":"Digestion"},{"key":"4047_CR23","doi-asserted-by":"publisher","first-page":"100223","DOI":"10.1016\/j.ejro.2020.100223","volume":"7","author":"A Chandramohan","year":"2020","unstructured":"Chandramohan A et al (2020) Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Radiol Open 7:100223","journal-title":"Eur J Radiol Open"},{"issue":"1","key":"4047_CR24","doi-asserted-by":"publisher","first-page":"e232838","DOI":"10.1148\/radiol.232838","volume":"314","author":"S Nougaret","year":"2025","unstructured":"Nougaret S et al (2025) MRI of the Rectum: A Decade into DISTANCE, Moving to DISTANCED. Radiology 314(1):e232838","journal-title":"Radiology"},{"issue":"7","key":"4047_CR25","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.ejso.2022.02.012","volume":"48","author":"C Suzuki","year":"2022","unstructured":"Suzuki C et al (2022) Initial magnetic resonance imaging tumour regression grade (mrTRG) as response evaluation after neoadjuvant treatment predicts sustained complete response in patients with rectal cancer. Eur J Surg Oncol 48(7):1643\u20131649","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"4047_CR26","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.surg.2015.10.019","volume":"159","author":"EA de Jong","year":"2016","unstructured":"de Jong EA et al (2016) The accuracy of MRI, endorectal ultrasonography, and computed tomography in predicting the response of locally advanced rectal cancer after preoperative therapy: A metaanalysis. Surgery 159(3):688\u2013699","journal-title":"Surgery"},{"issue":"3","key":"4047_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jmri.24835","volume":"42","author":"T Tong","year":"2015","unstructured":"Tong T et al (2015) Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. J Magn Reson Imaging 42(3):673\u2013680","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"4047_CR28","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.1007\/s00464-024-11084-3","volume":"38","author":"Y Zager","year":"2024","unstructured":"Zager Y et al (2024) The predicting value of post neoadjuvant treatment magnetic resonance imaging: a meta-analysis. Surg Endosc 38(11):6846\u20136853","journal-title":"Surg Endosc"},{"issue":"4","key":"4047_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/DCR.0000000000000742","volume":"60","author":"K Kawai","year":"2017","unstructured":"Kawai K et al (2017) Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer. Dis Colon Rectum 60(4):368\u2013375","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"4047_CR30","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00268-016-3661-4","volume":"40","author":"SG Lim","year":"2016","unstructured":"Lim SG, Kim YB, Oh SY (2016) Clinical significance of the endoscopic finding in predicting complete tumor response to preoperative chemoradiation therapy in rectal cancer. World J Surg 40(12):3029\u20133034","journal-title":"World J Surg"},{"issue":"11","key":"4047_CR31","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s00384-022-04268-7","volume":"37","author":"J Chen","year":"2022","unstructured":"Chen J et al (2022) Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer. Int J Colorectal Dis 37(11):2321\u20132333","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"4047_CR32","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1097\/SLA.0000000000003718","volume":"274","author":"ME van der Sande","year":"2021","unstructured":"van der Sande ME et al (2021) Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer. Ann Surg 274(6):e541\u2013e547","journal-title":"Ann Surg"},{"key":"4047_CR33","doi-asserted-by":"publisher","first-page":"101964","DOI":"10.1016\/j.ctrv.2020.101964","volume":"84","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Glynne-Jones R (2020) How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement. Cancer Treat Rev 84:101964","journal-title":"Cancer Treat Rev"},{"issue":"15","key":"4047_CR34","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1200\/JCO.2005.06.114","volume":"23","author":"JG Guillem","year":"2005","unstructured":"Guillem JG et al (2005) Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol 23(15):3475\u20133479","journal-title":"J Clin Oncol"},{"key":"4047_CR35","doi-asserted-by":"publisher","unstructured":"Williams H, Omer DM, Verheij FS, Thompson HM, Lin ST, Kim JK, Yuval JB, Lee C, Qin LX, Gollub MJ, Garcia-Aguilar J, OPRA Consortium (2025) Accuracy of Flexible Sigmoidoscopy and MRI in Restaging Rectal Cancer after Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial. Ann Surg 23. https:\/\/doi.org\/10.1097\/SLA.0000000000006960","DOI":"10.1097\/SLA.0000000000006960"},{"key":"4047_CR36","doi-asserted-by":"publisher","first-page":"101739","DOI":"10.1016\/j.suronc.2022.101739","volume":"43","author":"MC Fernandes","year":"2022","unstructured":"Fernandes MC, Gollub MJ, Brown G (2022) The importance of MRI for rectal cancer evaluation. Surg Oncol 43:101739","journal-title":"Surg Oncol"},{"issue":"7","key":"4047_CR37","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1007\/s00330-020-07657-0","volume":"31","author":"MJ Gollub","year":"2021","unstructured":"Gollub MJ et al (2021) Rectal cancer with complete endoscopic response after neoadjuvant therapy: what is the meaning of a positive MRI? Eur Radiol 31(7):4731\u20134738","journal-title":"Eur Radiol"},{"issue":"2","key":"4047_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/DCR.0b013e31827541e2","volume":"56","author":"MP Duldulao","year":"2013","unstructured":"Duldulao MP et al (2013) Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer. Dis Colon Rectum 56(2):142\u2013149","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"4047_CR39","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.clinre.2011.05.012","volume":"35","author":"P Marone","year":"2011","unstructured":"Marone P et al (2011) Accuracy of endoscopic ultrasound in staging and restaging patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation. Clin Res Hepatol Gastroenterol 35(10):666\u2013670","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"9","key":"4047_CR40","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/codi.12976","volume":"17","author":"S Memon","year":"2015","unstructured":"Memon S et al (2015) Systematic review and meta-analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy. Colorectal Dis 17(9):748\u2013761","journal-title":"Colorectal Dis"},{"issue":"9","key":"4047_CR41","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/DCR.0b013e31821c4a60","volume":"54","author":"C Pastor","year":"2011","unstructured":"Pastor C et al (2011) Accuracy of endoscopic ultrasound to assess tumor response after neoadjuvant treatment in rectal cancer: can we trust the findings? Dis Colon Rectum 54(9):1141\u20136","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"4047_CR42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/DCR.0000000000000022","volume":"57","author":"RS Zhao","year":"2014","unstructured":"Zhao RS et al (2014) Restaging of locally advanced rectal cancer with magnetic resonance imaging and endoluminal ultrasound after preoperative chemoradiotherapy: a systemic review and meta-analysis. Dis Colon Rectum 57(3):388\u2013395","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"4047_CR43","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1007\/s00330-023-09480-9","volume":"33","author":"JB Yuval","year":"2023","unstructured":"Yuval JB et al (2023) MRI assessment of rectal cancer response to neoadjuvant therapy: a multireader study. Eur Radiol 33(8):5761\u20135768","journal-title":"Eur Radiol"},{"issue":"4","key":"4047_CR44","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s11605-019-04119-x","volume":"23","author":"OS Chow","year":"2019","unstructured":"Chow OS et al (2019) Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation. J Gastrointest Surg 23(4):794\u2013799","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"4047_CR45","first-page":"102","volume":"18","author":"A Greenbaum","year":"2019","unstructured":"Greenbaum A et al (2019) Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Clin Colorectal Cancer 18(2):102\u2013109","journal-title":"Clin Colorectal Cancer"},{"issue":"8","key":"4047_CR46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.asjsur.2018.12.007","volume":"42","author":"SS Yeom","year":"2019","unstructured":"Yeom SS et al (2019) Non-operative treatment outcome for rectal cancer patient with clinical complete response after neoadjuvant chemoradiotherapy. Asian J Surg 42(8):823\u2013831","journal-title":"Asian J Surg"},{"issue":"2","key":"4047_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/1319-3767.178526","volume":"22","author":"V Lopez-Lopez","year":"2016","unstructured":"Lopez-Lopez V et al (2016) Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer. Saudi J Gastroenterol 22(2):148\u2013153","journal-title":"Saudi J Gastroenterol"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-026-04047-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-026-04047-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-026-04047-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:18:16Z","timestamp":1781648296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-026-04047-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4047"],"URL":"https:\/\/doi.org\/10.1007\/s00423-026-04047-w","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 194 Helsinki declaration and its later amendments or comparable ethical standards. This study is approved by the Ethical Committee of Friedrich-Alexander-University Erlangen-Nuremberg (ethical code number 25-385-Br).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal content is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}